Abbott, Shareholders Agree To Settle Depakote Marketing Suit
Abbott Laboratories shareholders asked an Illinois federal judge on Thursday to bless a settlement resolving a derivative suit that alleged Abbott's directors cost the company $1.6 billion because they did nothing...To view the full article, register now.
Already a subscriber? Click here to view full article